Page last updated: 2024-09-02

2'-5'-oligoadenylate trimer and irinotecan

2'-5'-oligoadenylate trimer has been researched along with irinotecan in 1 studies

Compound Research Comparison

Studies (2'-5'-oligoadenylate trimer)	Trials (2'-5'-oligoadenylate trimer)	Recent Studies (post-2010) (2'-5'-oligoadenylate trimer)	Studies (irinotecan)	Trials (irinotecan)	Recent Studies (post-2010) (irinotecan)
590	4	88	8,002	1,885	3,752

Protein Interaction Comparison

Protein	Taxonomy	irinotecan (IC50)
Solute carrier family 22 member 2	Homo sapiens (human)	2.7
Interstitial collagenase	Homo sapiens (human)	6.06
Muscarinic acetylcholine receptor M4	Homo sapiens (human)	1.556
Alpha-2C adrenergic receptor	Homo sapiens (human)	3.171
Acetylcholinesterase	Homo sapiens (human)	1.827
Multidrug and toxin extrusion protein 2	Homo sapiens (human)	7.9
Multidrug and toxin extrusion protein 1	Homo sapiens (human)	4.7667

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ganapathi, R; Malathi, K; Paranjape, JM; Silverman, RH	1

Other Studies

1 other study(ies) available for 2'-5'-oligoadenylate trimer and irinotecan

Article	Year
HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand. Cancer research, 2004, Dec-15, Volume: 64, Issue:24 Topics: Adenine Nucleotides; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Camptothecin; Drug Synergism; Endoribonucleases; Enzyme Inhibitors; Humans; Irinotecan; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Membrane Glycoproteins; Mitogen-Activated Protein Kinase Kinases; Oligoribonucleotides; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Topoisomerase I Inhibitors; Topotecan; Transfection; Tumor Necrosis Factor-alpha	2004

Article

Year

HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand.

Cancer research, 2004, Dec-15, Volume: 64, Issue:24

Topics: Adenine Nucleotides; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Camptothecin; Drug Synergism; Endoribonucleases; Enzyme Inhibitors; Humans; Irinotecan; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Membrane Glycoproteins; Mitogen-Activated Protein Kinase Kinases; Oligoribonucleotides; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Topoisomerase I Inhibitors; Topotecan; Transfection; Tumor Necrosis Factor-alpha

2004